ClinicalTrials.gg

Drug

Mibefradil clinical trials

Also written Posicor.

studies test it
3
open now
0
in phase 3
0
first study started
2012

How studies write it

Studies that test it under each name

Name

mibefradil
3

Brand

Posicor
2

Development codes

RO 40-5967
1

Studies by the year they started

3 studies that test it; most in 2012 (2)

Studies that test Mibefradil, by start year
YearStudies
20122
20141

By phase

A phase 1/2 study counts in both.

Phase 1
3

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 2 · Other 1

Cavion, Inc. (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

Often tested with

Tested in the same studies.

Temozolomide (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Mibefradil is read from its arms, and is right about nine times in ten.

Testing it · 3

Codes

What other systems call Mibefradil · ClinicalTrials.gg INT008768

  • MeSH (NLM) D020748MibefradilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 27B90X776AMIBEFRADILConfirmed FDA, NLM, Wikidata
  • RxNorm 83213Confirmed FDA, Wikidata
  • Wikidata Q6827783mibefradilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87686MibefradilOne source FDA
  • DrugBank DB01388One source Wikidata

Also registered as mibefradil dihydrochloride (UNII 842TUP3PQ8 · RxNorm 83214).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.